Currently, thalidomide is under investigation to treat neurodegenerative disorders that implicate TNF-signaling such as AD, PD and amyotrophic lateral sclerosis (ALS) as this small-drug molecule can penetrate into the brain [235,339,340,341,342]. This evidence concerns the gene TNF and Parkinson disease.